St. John’s Wort - Depression (Depression)

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression–a double-blind, randomized, placebo controlled long-term trial

Study link https://pubmed.ncbi.nlm.nih.gov/18694635/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Randomized, Double Blind, Controlled Clinical Trial

Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode – a subgroup analysis

Study link https://pubmed.ncbi.nlm.nih.gov/27161105/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Clinical Trial

Efficacy of St. John’s wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial

Study link https://pubmed.ncbi.nlm.nih.gov/12153829/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Randomized, Double Blind, Controlled Clinical Trial

Role in depression of a multi-fractionated versus a conventional Hypericum perforatum extract

Study link https://pubmed.ncbi.nlm.nih.gov/29991209/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Clinical Trial

St John’s wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT

Study link https://pubmed.ncbi.nlm.nih.gov/22592504/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Randomized, Controlled Clinical Trial

Subchronic treatment with St John’s wort produces a positive shift in emotional processing in healthy volunteers

Study link https://pubmed.ncbi.nlm.nih.gov/30484733/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Randomized, Controlled Clinical Trial

Superior efficacy of St John’s wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

Study link https://pubmed.ncbi.nlm.nih.gov/16796730/

Health Goal Depression

Dietary Supplement St. John’s Wort

Study Level Randomized, Double Blind, Controlled Clinical Trial

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression–a double-blind, randomized, placebo controlled long-term trial

Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode – a subgroup analysis

Efficacy of St. John’s wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial

Role in depression of a multi-fractionated versus a conventional Hypericum perforatum extract

St John’s wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT

Subchronic treatment with St John’s wort produces a positive shift in emotional processing in healthy volunteers

Superior efficacy of St John’s wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

Our Company

Knowledge Base

St. John’s Wort – Depression (Depression)

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression–a double-blind, randomized, placebo controlled long-term trial

Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode – a subgroup analysis

Efficacy of St. John’s wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial

Role in depression of a multi-fractionated versus a conventional Hypericum perforatum extract

St John’s wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT

Subchronic treatment with St John’s wort produces a positive shift in emotional processing in healthy volunteers

Superior efficacy of St John’s wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]